Bioelectronic Medicine

Cala Health Announces Continued Growth and Momentum with Clinical, Product Development, and Management Milestones to Support Cala Trio Therapy for the Treatment of Essential Tremor | Malvern Daily Record | 8/17/2020

Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, today announced that data from its landmark PRO spective study for S ym P tomatic relief of E ssential tremor with C ala T herapy (PROSPECT), was published in Tremor and Other Hyperkinetic Movements . This important study demonstrated that the company’s FDA cleared, neuromodulation therapy, Cala Trio™, repeatedly used at home over three months resulted in safe …

electroCore Announces Second Quarter Financial Results | BioSpace | 8/14/2020

BASKING RIDGE, N.J., Aug. 13, 2020 (GLOBE NEWSWIRE) – electroCore , Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced second quarter 2020 financial results and provided an operational update. Second Quarter 2020 and Recent Highlights Obtained Emergency Use Authorization (EUA) for the use of gammaCore Sapphire CV (non-invasive nerve stimulation or nVNS) in known or suspected COVID-19 patients who are experiencing an exacerbation of asthma-related dyspnea …

Follow Bioelectronic Medicine:    

Non-Invasive Nerve Stimulation Boosts Learning of Foreign Language | 8/12/2020

… of the 12 cranial nerves that connect the brain to the rest of the body. What’s more, vagus nerve stimulation allowed research participants to pick up some Mandarin tones twice as quickly. For more Bioelectronic Medicine 2019-2029 . “This is one of the first demonstrations that non-invasive vagus nerve stimulation can enhance a complex cognitive skill like language learning in healthy people,” added Matthew Leonard, PhD, an assistant professor in …

Input-output signal processing plasticity of vagal motorneurons in response to cardiac ischemic injury | 8/10/2020

Vagal stimulation is emerging as the next frontier in bioelectronic medicine to modulate peripheral organ health and treat disease. The neuronal molecular phenotypes in the dorsal motor nucleus of the vagus (DMV) remain largely unexplored, limiting the potential for harnessing the DMV plasticity for therapeutic interventions. We developed a mesoscale single cell transcriptomics data from hundreds of DMV neurons under homeostasis and following physiological perturbations. Our results revealed that homeostatic …

electroCore to Announce Second Quarter Ended June 30, 2020 Financial Results on Thursday, August 13 | 8/7/2020

Conference Call to be Held at 4:30pm Eastern Time BASKING RIDGE, N.J., electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the second quarter ended June 30, 2020 after the close of the market on Thursday, August 13, 2020. Management will host a conference call and webcast at 4:30pm Eastern Time to discuss the financial results and answer questions. Thursday, August …

Large-Scale COVID-19 Antibody Testing of Frontline Health Care Workers Reveals Prevalence | Business Wire | 8/6/2020

… in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine , cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that …

Critical Survey: electroCore (NASDAQ:ECOR) & InMode (NASDAQ:INMD) | 8/4/2020

… money managers and hedge funds believe a company is poised for long-term growth. Summary InMode beats electroCore on 10 of the 13 factors compared between the two stocks. About electroCore electroCore, Inc., a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a …

Grandparents Raising Grandchildren in the United States: New Research Into Characteristics and Challenges | Business Wire | 8/3/2020

… in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine , cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that …

electroCore Provides Update on Availability of gammaCore Sapphire(TM) CV for the Acute Treatment of Asthma Exacerbations in Known or Suspected COVID-19 Patients - Stockhouse | 7/30/2020

… COVID-19 Patients ECOR 19 hours ago Initial distribution to hospitals and patients expected to begin on July 31st BASKING RIDGE, N.J., July 30, 2020 (GLOBE NEWSWIRE) – electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced more information about availability, distribution and pricing for gammaCore Sapphire™ CV non-invasive vagus nerve stimulation (nVNS) therapy under its Emergency Use Authorization (EUA). The EUA allows for the use of …

electroCore Provides Update on Availability of gammaCore Sapphire™ CV for the Acute Treatment of Asthma Exacerbations in Known or Suspected COVID-19 Patients - GuruFocus.com | 7/30/2020

Initial distribution to hospitals and patients expected to begin on July 31st BASKING RIDGE, N.J., July 30, 2020 (GLOBE NEWSWIRE) – electroCore, Inc. ( ECOR), a commercial-stage bioelectronic medicine company, today announced more information about availability, distribution and pricing for gammaCore Sapphire™ CV non-invasive vagus nerve stimulation (nVNS) therapy under its Emergency Use Authorization (EUA). The EUA allows for the use of gammaCore Sapphire™ CV at home or in a …

Associate in Research | 7/30/2020

… Computational Modeling of Autonomic Neuromodulation The Grill Lab at Duke University, Department of Biomedical Engineering seeks a highly-motivated individual to pursue neural engineering research in a supportive environment. Our goal is to advance bioelectronic medicine s: electrical stimulation, block, and recording of peripheral autonomic nerves for disease treatment and restoration of function. We have an NIH-funded SPARC project to develop, validate, and apply computer-based models of electrical stimulation …

The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in Patients with Drug Refractory Rheumatoid Arthritis | Globe Newswire | 7/29/2020

… resolved without clinically significant sequelae. Full results published in The Lancet Rheumatology available online: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30172-7/fulltext About SetPoint Medical SetPoint Medical is a privately held clinical-stage bioelectronic medicine company dedicated to treating patients with chronic autoimmune diseases. SetPoint Medical’s bioelectronic medicine platform is intended to offer patients and providers a treatment alternative for rheumatoid arthritis, inflammatory bowel disease and other chronic autoimmune …

FDA Green Light Makes ElectroCore a Micro-Cap to Watch | 7/29/2020

… Light Makes ElectroCore a Micro-Cap to Watch Heightened trading volume is justified in bioelectronic boomer ECOR stock By David Moadel , InvestorPlace Contributor Jul 29, 2020, 12:21 pm EDT July 29, 2020 Commercial-stage bioelectronic medicine company ElectroCore (NASDAQ: ECOR ) largely flew under most traders’ radars prior to the onset of the novel coronavirus. But as experienced medical-company investors know, it just takes one regulatory decision to change everything …

electroCore Announces Non-Invasive Vagus Nerve Stimulation Clinical Update Publication in Cephalalgia Nasdaq:ECOR | Globe Newswire | 7/28/2020

BASKING RIDGE, N.J., July 28, 2020 (GLOBE NEWSWIRE) – electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a paper, entitled, “Non-invasive vagus nerve stimulation for primary headache: a clinical update,” 1 in Cephalalgia, the official journal of the International Headache Society (IHS). The paper is a narrative review of recent scientific and clinical research into non-invasive vagus nerve stimulation (nVNS) for headache …

electroCore Announces Non-Invasive Vagus Nerve Stimulation Clinical Update Publication in Cephalalgia - Stockhouse | 7/28/2020

… for acute and preventative treatment of cluster headache and as an effective option for the treatment of migraine headache BASKING RIDGE, N.J., July 28, 2020 (GLOBE NEWSWIRE) – electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a paper, entitled, “Non-invasive vagus nerve stimulation for primary headache: a clinical update,” 1 in Cephalalgia, the official journal of the International Headache Society (IHS). The …

Endometriosis Research Provides New Origin Clues, Potential Diagnostic and Possible Treatment Avenues | Business & Finance | manchestertimes.com | Business Wire | 7/22/2020

… in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine , cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that …

A mechanical way to stimulate neurons | Phys Org | 7/20/2020

… an interface between the central and peripheral nervous systems, because these cells are particularly sensitive to mechanical forces. The applications of the technique could be similar to those being developed in the field of bioelectronic medicine s, Senko says, but those require electrodes that are typically much bigger and stiffer than the neurons being stimulated, limiting their precision and sometimes damaging cells. The key to the new process was developing minuscule …

Feinstein Institutes Receives $15 Million NIH Grant to Study Brain Dysfunction in Lupus | Business & Finance | manchestertimes.com | Business Wire | 7/20/2020

… in New York State. Home to 50 research labs, 2,500 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine , cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that …

AI is a ‘key ally in the fight’ against COVID-19, say Northwell researchers | Becker’s Hospital Review | 7/13/2020

Artificial intelligence and machine learning tools can be a vital aspect of the COVID-19 response, and some are already used by clinicians worldwide. A team of researchers led by Theodoros Zanos, PhD, an assistant professor at the Northwell Health’s Institute of Bioelectronic Medicine at Feinstein in New York City, wrote an article for the Springer Nature journal outlining the potential for critical care decision-making tools that include information …

Picosun’s medical ALD solutions ensure excellent hermetic encapsulation | 6/29/2020

Picosun’s medical ALD solutions ensure excellent hermetic encapsulation Mon, Jun 29, 2020 02:00 CET ESPOO, Finland, 29 th June 2020 – Picosun Group reports excellent results in ALD-organic bilayer encapsulation of metal electrodes for neuroprosthetics and bioelectronic medicine . Group also reports superior hermetic barrier performance of its ALD nanolaminates against corrosive ion diffusion in aqueous media. This is an important result for medical ALD applications and implantology, where metal components …

Picosun’s Medical ALD Solutions Ensure Excellent Hermetic Encapsulation | 6/29/2020

ESPOO, Finland , June 29, Picosun Group reports excellent results in ALD-organic bilayer encapsulation of metal electrodes for neuroprosthetics and bioelectronic medicine . Group also reports superior hermetic barrier performance of its ALD nanolaminates against corrosive ion diffusion in aqueous media. This is an important result for medical ALD applications and implantology, where metal components and sensitive microelectronics need to be protected against corrosion caused by human body fluids. Picosun’s ALD …

Advances in bioelectronic medicine give movement back to paralyzed person | The Big Idea | FOX 5 New York | 6/26/2020

… I went backwards. I needed help with everything. It was shell shock. It just kind of hit me.” But thanks to the work at Feinstein Institutes for Medical Research at Northwell Health in Manhasset , bioelectronic medicine may change his life for the better. Neurosurgeon-turned-scientist Dr. Kevin Tracey said significant strides have been made over the past several years. “Bioelectronic medicine is the process of building medical devices that …

Top Companies To Short As Nasdaq Looks To Break 10,000 | 6/17/2020

… Top Shorts today. electroCore Inc (ECOR) First on the list is a company that has repeatedly been recommended as a short on our daily list, in electroCore Inc. This company is a commercial stage bioelectronic medicine company but has been given poor factor scores of D in Technical, C in Growth, D in Momentum Volatility, and C in Quality Value from our AI systems. The stock is already down 36.76 …

CEO Ryan explains how Cala Health is building bioelectronic medicine business | Medical Design and Outsourcing | 6/12/2020

… tremors? What grade did she skip as a child? Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players. DeviceTalks by MassDevice · Cala Health CEO Renee Ryan Brings Business Building Insights to Bioelectronic Medicine Startup …

Tiny, Magnetically Powered Neural Stimulator | 6/11/2020

… the first magnetically powered neural stimulator that produces the same kind of high- frequency signals as clinically approved, battery-powered implants that are used to treat epilepsy, Parkinson’s disease, chronic pain and other conditions. Bioelectronic Medicine 2019-2029 . The implant’s key ingredient is a thin film of “magnetoelectric” material that converts magnetic energy directly into an electrical voltage. The method avoids the drawbacks of radio waves, ultrasound, light and even magnetic …

COVID-19

Large-Scale COVID-19 Antibody Testing of Frontline Health Care Workers Reveals Prevalence | Business Wire | 8/6/2020

… shows that Northwell Health, the largest health system in New York, kept its staff safe during the coronavirus disease 2019 (COVID-19) pandemic. This data, published today in The Journal of Medical Association (JAMA) , demonstrates … of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global …

NIH

Feinstein Institutes Receives $15 Million NIH Grant to Study Brain Dysfunction in Lupus | Business & Finance | manchestertimes.com | Business Wire | 7/20/2020

… cause permanent cognitive impairment in their children who are exposed to these antibodies in pregnancy,” said Dr. Diamond. “With the NIH’s support, we will study if common medications could protect against these negative effects of … of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global …

Medical Research

Largest COVID-19 Study of Hospitalized Patients in US Links Comorbidities to Acuity | Business Wire | 4/22/2020

… published (Credit: Lee Weissman @ Northwell Health) The Northwell Health COVID-19 Research Consortium, with support from the Feinstein Institutes for Medical Research , described the clinical course and outcomes of 5,700 Northwell patients hospitalized with COVID … of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global …

Food and Drug Administration

Feinstein Institutes to Collect COVID-19 Patient Plasma, Research Antibodies Therapy | Business Wire | 4/10/2020

… here: https://www.businesswire.com/news/home/20200410005113/en/ Feinstein Institutes scientists look at a test tube. (Credit: Northwell Health) The US Food and Drug Administration has outlined enrollment criteria. To be considered to participate, a person … of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global …

Mental Health

Feinstein Institutes CEO to Present Elsberg Lecture About Bioelectronic Medicine | Business Wire | 1/28/2020

… J. Tracey, MD , will present the New York Society for Neurosurgery (NYSN) 2020 Elsberg Lecture about the emerging field of bioelectronic medicine . Dr. Tracey’s lecture will be delivered January 29 at 6:30 pm at The … molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For …

Clinical Research

Feinstein Institutes CEO to Present Elsberg Lecture About Bioelectronic Medicine | Business Wire | 1/28/2020

… J. Tracey, MD , will present the New York Society for Neurosurgery (NYSN) 2020 Elsberg Lecture about the emerging field of bioelectronic medicine . Dr. Tracey’s lecture will be delivered January 29 at 6:30 pm at The … in New York State. Home to 50 research labs, 2,500 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic …

National Institutes of Health

Micro-Leads Announces $10M in Funding for Precision Neuromodulation Therapy | PR Newswire | 12/3/2019

… the Department of Neuroscience and Experimental Therapeutics and professor of Neurosurgery at Albany Medical College. The funding is from the National Institutes of Health initiative Helping to End Addiction Long-Term (HEAL) and private investors … dedicated to developing innovative therapies that address the neuromodulation and bioelectronic medicine market. Micro-Leads is developing a high-resolution spinal cord stimulation therapy to treat chronic back and focal pains without opioids. For more …

Medical Innovation

New clues link genomic origins of memory impairment | PR Newswire | 12/2/2019

… ERV and memory disruption in mammals,” said Yousef Al-Abed , PhD, Dr. Sankowski’s mentor, the Director of the Institute of Bioelectronic Medicine , and co-author on the paper. “We now better appreciate the molecular basis … and staff, the Feinstein Institutes is raising the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We’re making breakthroughs in genetics, oncology …

Medical Education

BioSig Technologies Partners Mayo Clinic to Treat Arrhythmia - December 2, 2019 - Zacks.com | 12/2/2019

… company and its majority-owned subsidiary have inked three new patent and know-how license deals with Mayo Foundation for Medical Education and Research. Per the terms of the agreement, BioSig will start working on … and support in the launch of the Alliance for Advancing Bioelectronic Medicine (AABM), an independent network of professionals united to support bioelectronic medicine in November 2019. In September, BioSig entered into a new licensing agreement …

American College of Rheumatology

New data shows benefit of lupus drug | PR Newswire | 11/11/2019

… publish and present data describing the clinical benefit of anifrolumab for patients with lupus in Lancet Rheumatology and at the American College of Rheumatology’s Annual Scientific Meeting. Dr. Richard Furie with a patient Anifrolumab is … of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We’re making breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a …

Clinical Data

electroCore Provides Update on 510(k) Submission Seeking Expanded Indication for gammaCore™ | Globe Newswire | 9/25/2019

Additional information requested by FDA; Premium 2 trial progressing as planned September 25, 2019 08:00 ET Source: electroCore, Inc. BASKING RIDGE, N.J., Sept. 25, 2019 (GLOBE NEWSWIRE) – electroCore, Inc. (Nasdaq: ECOR, or the “Company”), a commercial-stage bioelectronic medicine company, today announced that the U.S. Food and Drug Administration (“FDA”) has requested more information and analysis of the clinical data included in the Company’s premarket notification, or “510(k)” submission …

ACA

New therapies changing drug companies with hospitals’ help | Modern Healthcare | 8/24/2019

… of four major new therapies that hold the potential to transform care with a handful of hospitals leading the charge. Bioelectronic medicine Nerve stimulators have been used to treat conditions like epilepsy for decades. But … leadership position, published results of a clinical trial with the Academic Medical Centre, a hospital affiliated with the University of Amsterdam in the Netherlands. It was the first study to look at the efficacy of …

Diabetes Management

Feinstein Institutes discovery may have implications for diabetes management and therapy | PR Newswire | 7/11/2019

… MANHASSET, N.Y. , July 10, Theodoros Zanos , PhD , head of the Neural & Data Science Lab & assistant professor at the Institute of Bioelectronic Medicine, The Feinstein Institutes for Medical Research , and his collaborators, discovered how the vagus … understanding of the body’s neural signaling and offers hope for diabetes management,” said Dr. Tracey. Bioelectronic medicine is a new approach to treating and diagnosing disease and injury that has emerged from the Feinstein Institutes …

Biotech

Top U.S. cancer specialists exchange ideas of promising new therapies at Feinstein Institute’s Brain Tumor Biotech Summit | PR Newswire | 6/11/2019

MANHASSET, N.Y. At the sixth annual Feinstein Institute for Medical Research Brain Tumor Biotech Summit held June 7 at Northwell Health’s Lenox Hill Hospital , leaders in neurosurgery, neuroscience, oncology and industry professionals from across the … molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we empower imagination and pioneer discovery …

Cala Health

Cala Health Announces Continued Growth and Momentum with Clinical, Product Development, and Management Milestones to Support Cala Trio Therapy for the Treatment of Essential Tremor | Business Wire | 8/17/2020

BURLINGAME, Calif.–(BUSINESS WIRE)–Aug 17, 2020– Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, today announced that data from its landmark PRO spective study for S ym P tomatic relief of E ssential tremor with C ala T herapy (PROSPECT), was published in Tremor and Other Hyperkinetic Movements . This important study demonstrated that the company’s FDA cleared, neuromodulation therapy, Cala Trio™, repeatedly used at …

electroCore

electroCore Provides Update on COVID-19 Clinical Initiatives | Globe Newswire | 4/27/2020

… electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today provided an update on ongoing nVNS COVID-19 initiatives. The company announced today that an investigator-initiated, randomized, controlled clinical trial of nVNS therapy has commenced enrolling COVID-19 patients in Spain. The trial, “Prospective, Randomized, Controlled Study to Evaluate the Effect of Non-Invasive Electrical Vagus Nerve Stimulation on Respiratory Symptoms due to COVID-19 (SAVIOR),” is designed …

BioSig Technologies

Jerome Zeldis, M.D., Ph.D, Appointed as Executive Chair of ViralClear Pharmaceuticals, Inc. | Globe Newswire | 3/31/2020

… Vicromax(tm), a novel broad-spectrum anti-viral agent that may treat COVID-19 March 31, 2020 08:45 ET Source: BioSig Technologies, Inc. Westport, CT, March 31, BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the … Company aims to address some of the biggest challenges of bioelectronic medicine devices through targeted stimulation and feedback loops for optimal therapy delivery. Forward-looking Statements This press release contains “forward-looking statements.” Such statements …

Merck & Co

BioSig subsidiary NeuroClear acquires license for a broad-spectrum anti-viral agent that may treat COVID-19. Laboratory results demonstrate high level of activity against COVID-19 in cell culture | Globe Newswire | 3/25/2020

… is a seasoned global executive and entrepreneur with experience spanning both human and animal health. During his extensive career at Merck & Co., he led the worldwide franchise for live viral human vaccines as well as … Company aims to address some of the biggest challenges of bioelectronic medicine devices through targeted stimulation and feedback loops for optimal therapy delivery. Forward-looking Statements This press release contains “forward-looking statements.” Such statements …

CVS

Tivic Health’s ClearUP Sinus Pain Relief Named To TIME’S List Of The 100 Best Inventions Of 2019 | PR Newswire | 11/22/2019

… million Americans suffering from allergic rhinitis. Available now over the counter and without a prescription. ClearUP is an example of bioelectronic medicine, an emerging form of drug free, non-invasive medicine that uses low-level … is available at Amazon, BestBuy.com, https://tivichealth.com and online at CVS and Walgreens later this month. About Tivic Health Systems Inc. Tivic Health Systems Inc. is a bioelectronic device company dedicated to developing microcurrent therapy …

Amazon Health

Tivic Health’s ClearUP Sinus Pain Relief Named To TIME’S List Of The 100 Best Inventions Of 2019 | PR Newswire | 11/22/2019

… million Americans suffering from allergic rhinitis. Available now over the counter and without a prescription. ClearUP is an example of bioelectronic medicine, an emerging form of drug free, non-invasive medicine that uses low-level … to six hours. Priced at $149 , ClearUP is available at Amazon, BestBuy.com, https://tivichealth.com and online at CVS and Walgreens later this month. About Tivic Health Systems Inc. Tivic Health Systems Inc. is a bioelectronic …

Walgreens Healthcare

Tivic Health’s ClearUP Sinus Pain Relief Named To TIME’S List Of The 100 Best Inventions Of 2019 | PR Newswire | 11/22/2019

… million Americans suffering from allergic rhinitis. Available now over the counter and without a prescription. ClearUP is an example of bioelectronic medicine, an emerging form of drug free, non-invasive medicine that uses low-level … at Amazon, BestBuy.com, https://tivichealth.com and online at CVS and Walgreens later this month. About Tivic Health Systems Inc. Tivic Health Systems Inc. is a bioelectronic device company dedicated to developing microcurrent therapy solutions for …

Boston Scientific

SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019 | Globe Newswire | 11/14/2019

… Emma Poalillo of The Ruth Group at [email protected] . About SetPoint Medical SetPoint Medical is a privately held clinical-stage bioelectronic medicine company dedicated to treating patients with chronic autoimmune diseases. SetPoint Medical’s bioelectronic medicine … Topspin Partners, Sightline Partners, GlaxoSmithKline’s Action Potential Venture Capital and Boston Scientific as well as an additional undisclosed strategic investor (leading medical device company). For more information, visit www.setpointmedical.com . Contacts …

Medtronic

Sensydia Appoints President and CEO | 11/12/2019

bioelectronic medicine and surgical navigation and brings more than 20 years of leadership experience from a range of medical technology companies including Smith+Nephew plc, Medtronic plc, Boston Scientific Corp., and SetPoint Medical. “Anthony’s appointment comes at an exciting time for Sensydia, as the company builds on its lead product, the FDA-approved Cardiac Performance System (CPS), to strengthen and expand its technical capabilities and clinical applications,” said Aman Mahajan …

Johnson & Johnson

Veteran life sciences venture capitalist named new CEO at Cala Health | MedCity News | 9/5/2019

Renee Ryan, until recently a venture capitalist at Johnson & Johnson’s venture arm, is now going to lead Burlingame, California-based Cala Health as its new chief executive officer. Post a comment / Sep 4, 2019 at … that is highly committed to serving patients with our innovation bioelectronic medicine and business model. It continues my journey to get closer to patients.” In May, Cala Health raised $50 million to advance the commercialization …

GlaxoSmithKline

New therapies changing drug companies with hospitals’ help | Modern Healthcare | 8/24/2019

… of four major new therapies that hold the potential to transform care with a handful of hospitals leading the charge. Bioelectronic medicine Nerve stimulators have been used to treat conditions like epilepsy for decades. But … Scientific and Medtronic are among SetPoint’s investors. And in 2016, GlaxoSmithKline and Alphabet’s life sciences arm, Verily, formed a joint venture called Galvani Bioelectronics to develop and commercialize their own products that use bioelectronic medicine

Topspin Partners

SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019 | Globe Newswire | 11/14/2019

… Emma Poalillo of The Ruth Group at [email protected] . About SetPoint Medical SetPoint Medical is a privately held clinical-stage bioelectronic medicine company dedicated to treating patients with chronic autoimmune diseases. SetPoint Medical’s bioelectronic medicine … in the company include New Enterprise Associates (NEA), Morgenthaler Ventures, Topspin Partners, Sightline Partners, GlaxoSmithKline’s Action Potential Venture Capital and Boston Scientific as well as an additional undisclosed strategic investor (leading medical device company). For …

SetPoint Medical Announces Oral Presentation of Results from U.S. Pilot Study in Rheumatoid Arthritis Patients at American College of Rheumatology (ACR) Annual Meeting 2019 | Globe Newswire | 10/29/2019

… October 29, 2019 09:00 ET Source: SetPoint Medical VALENCIA, Calif., Oct. 29, 2019 (GLOBE NEWSWIRE) – SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that results from its … in the company include New Enterprise Associates (NEA), Morgenthaler Ventures, Topspin Partners, Sightline Partners, GlaxoSmithKline’s Action Potential Venture Capital and Boston Scientific as well as an additional undisclosed strategic investor (leading medical device company). For …

New Enterprise Associates

SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019 | Globe Newswire | 11/14/2019

… Emma Poalillo of The Ruth Group at [email protected] . About SetPoint Medical SetPoint Medical is a privately held clinical-stage bioelectronic medicine company dedicated to treating patients with chronic autoimmune diseases. SetPoint Medical’s bioelectronic medicine … systemic immune-restorative effect. Current investors in the company include New Enterprise Associates (NEA), Morgenthaler Ventures, Topspin Partners, Sightline Partners, GlaxoSmithKline’s Action Potential Venture Capital and Boston Scientific as well as an additional undisclosed strategic …

SetPoint Medical Announces Oral Presentation of Results from U.S. Pilot Study in Rheumatoid Arthritis Patients at American College of Rheumatology (ACR) Annual Meeting 2019 | Globe Newswire | 10/29/2019

… October 29, 2019 09:00 ET Source: SetPoint Medical VALENCIA, Calif., Oct. 29, 2019 (GLOBE NEWSWIRE) – SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that results from its … systemic immune-restorative effect. Current investors in the company include New Enterprise Associates (NEA), Morgenthaler Ventures, Topspin Partners, Sightline Partners, GlaxoSmithKline’s Action Potential Venture Capital and Boston Scientific as well as an additional undisclosed strategic …

SightLine Partners

SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019 | Globe Newswire | 11/14/2019

… Emma Poalillo of The Ruth Group at [email protected] . About SetPoint Medical SetPoint Medical is a privately held clinical-stage bioelectronic medicine company dedicated to treating patients with chronic autoimmune diseases. SetPoint Medical’s bioelectronic medicine … company include New Enterprise Associates (NEA), Morgenthaler Ventures, Topspin Partners, Sightline Partners, GlaxoSmithKline’s Action Potential Venture Capital and Boston Scientific as well as an additional undisclosed strategic investor (leading medical device company). For more information …

SetPoint Medical Announces Oral Presentation of Results from U.S. Pilot Study in Rheumatoid Arthritis Patients at American College of Rheumatology (ACR) Annual Meeting 2019 | Globe Newswire | 10/29/2019

… October 29, 2019 09:00 ET Source: SetPoint Medical VALENCIA, Calif., Oct. 29, 2019 (GLOBE NEWSWIRE) – SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that results from its … company include New Enterprise Associates (NEA), Morgenthaler Ventures, Topspin Partners, Sightline Partners, GlaxoSmithKline’s Action Potential Venture Capital and Boston Scientific as well as an additional undisclosed strategic investor (leading medical device company). For more information …

Morgenthaler

SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019 | Globe Newswire | 11/14/2019

… Emma Poalillo of The Ruth Group at [email protected] . About SetPoint Medical SetPoint Medical is a privately held clinical-stage bioelectronic medicine company dedicated to treating patients with chronic autoimmune diseases. SetPoint Medical’s bioelectronic medicine … Current investors in the company include New Enterprise Associates (NEA), Morgenthaler Ventures, Topspin Partners, Sightline Partners, GlaxoSmithKline’s Action Potential Venture Capital and Boston Scientific as well as an additional undisclosed strategic investor (leading medical device …

SetPoint Medical Announces Oral Presentation of Results from U.S. Pilot Study in Rheumatoid Arthritis Patients at American College of Rheumatology (ACR) Annual Meeting 2019 | Globe Newswire | 10/29/2019

… October 29, 2019 09:00 ET Source: SetPoint Medical VALENCIA, Calif., Oct. 29, 2019 (GLOBE NEWSWIRE) – SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that results from its … Current investors in the company include New Enterprise Associates (NEA), Morgenthaler Ventures, Topspin Partners, Sightline Partners, GlaxoSmithKline’s Action Potential Venture Capital and Boston Scientific as well as an additional undisclosed strategic investor (leading medical device …

Sand Hill Angels

Tivic Health Systems Inc. Receives ISO 13485:2016 Certification for ClearUP Sinus Pain Relief | PR Newswire | 11/14/2019

… give millions with chronic conditions access to health solutions that are easily accessible and affordable.” ClearUP is an example of bioelectronic medicine, an emerging form of drug free, non-invasive medicine that uses low-level … Tivic Health received an $8 million series seed investment from Sand Hill Angels, Astia Angels, Golden Seeds , HBS Angels, Sierra Angels, Lateral Capital, Skylight Investments, a physician network and individual investors. The company has raised …

Handheld allergy relief device maker raises $8M in seed funding | MobiHealthNews | 7/24/2019

… Systems, maker of a commercial sinus pain relief device, announced yesterday that it has raised $8 million in seed funding. Sand Hill Angels, Astia Angels, Golden Seeds, HBS Angels, Sierra Angels, Lateral Capital, Skylight Investments … a high growth industry and is expanding rapidly. Until recently, bioelectronic medicine has been accessible primarily through implantable devices,” Jennifer Ernst, CEO and co-founder of Tivic Health, said in a statement. “Today more companies …

Astia Angels

Tivic Health Systems Inc. Receives ISO 13485:2016 Certification for ClearUP Sinus Pain Relief | PR Newswire | 11/14/2019

… give millions with chronic conditions access to health solutions that are easily accessible and affordable.” ClearUP is an example of bioelectronic medicine, an emerging form of drug free, non-invasive medicine that uses low-level … an $8 million series seed investment from Sand Hill Angels, Astia Angels, Golden Seeds , HBS Angels, Sierra Angels, Lateral Capital, Skylight Investments, a physician network and individual investors. The company has raised funds in a …

Handheld allergy relief device maker raises $8M in seed funding | MobiHealthNews | 7/24/2019

… a commercial sinus pain relief device, announced yesterday that it has raised $8 million in seed funding. Sand Hill Angels, Astia Angels, Golden Seeds, HBS Angels, Sierra Angels, Lateral Capital, Skylight Investments, an unnamed physician … a high growth industry and is expanding rapidly. Until recently, bioelectronic medicine has been accessible primarily through implantable devices,” Jennifer Ernst, CEO and co-founder of Tivic Health, said in a statement. “Today more companies …

Skylight Investment

Tivic Health Systems Inc. Receives ISO 13485:2016 Certification for ClearUP Sinus Pain Relief | PR Newswire | 11/14/2019

… give millions with chronic conditions access to health solutions that are easily accessible and affordable.” ClearUP is an example of bioelectronic medicine, an emerging form of drug free, non-invasive medicine that uses low-level … Astia Angels, Golden Seeds , HBS Angels, Sierra Angels, Lateral Capital, Skylight Investments, a physician network and individual investors. The company has raised funds in a series of tranches. With initial investments in 2017 and 2018 …

Handheld allergy relief device maker raises $8M in seed funding | MobiHealthNews | 7/24/2019

… has raised $8 million in seed funding. Sand Hill Angels, Astia Angels, Golden Seeds, HBS Angels, Sierra Angels, Lateral Capital, Skylight Investments, an unnamed physician network and individual investors each backed the company through a … a high growth industry and is expanding rapidly. Until recently, bioelectronic medicine has been accessible primarily through implantable devices,” Jennifer Ernst, CEO and co-founder of Tivic Health, said in a statement. “Today more companies …

Merck Global Health Innovation Fund

Term Sheet – Thursday, November 30 | Fortune | 11/30/2017

… led the round, and was joined by investors including Revolution Growth and GreatPoint Ventures. • ElectroCore , a Basking Ridge, N.J.-based bioelectronic medicine healthcare company, raised more than $70 million in Series B funding. Core Ventures … Series C funding. Investors including Cigna, Hermed, Hikma Ventures, Maywic, Merck Global Health Innovation Fund, Safeguard Scientifics and GIS Strategic Ventures. • Deposit Solutions , a Germany-based open banking platform for deposits, raised $20 million in …

electroCore Completes $70 Million Series B Funding Round | PR Newswire | 11/29/2017

… clinical development of nVNS News provided by 08:45 ET Share this article BASKING RIDGE, N.J. , Nov. electroCore, a U.S.-based bioelectronic medicine healthcare company advancing better patient therapies through superior approaches to neuromodulation, announced today … or on the order of a licensed healthcare provider. About Merck Global Health Innovation Fund With a vision that data will be the currency in healthcare, Merck GHI is building a carefully integrated portfolio of …

Merck Global Health Innovation

Term Sheet – Thursday, November 30 | Fortune | 11/30/2017

… led the round, and was joined by investors including Revolution Growth and GreatPoint Ventures. • ElectroCore , a Basking Ridge, N.J.-based bioelectronic medicine healthcare company, raised more than $70 million in Series B funding. Core Ventures … Series C funding. Investors including Cigna, Hermed, Hikma Ventures, Maywic, Merck Global Health Innovation Fund, Safeguard Scientifics and GIS Strategic Ventures. • Deposit Solutions , a Germany-based open banking platform for deposits, raised $20 million in …

electroCore Completes $70 Million Series B Funding Round | PR Newswire | 11/29/2017

… clinical development of nVNS News provided by 08:45 ET Share this article BASKING RIDGE, N.J. , Nov. electroCore, a U.S.-based bioelectronic medicine healthcare company advancing better patient therapies through superior approaches to neuromodulation, announced today … or on the order of a licensed healthcare provider. About Merck Global Health Innovation Fund With a vision that data will be the currency in healthcare, Merck GHI is building a carefully integrated portfolio of …

Northwell Health

AI is a ‘key ally in the fight’ against COVID-19, say Northwell researchers | Becker’s Hospital Review | 7/13/2020

Artificial intelligence and machine learning tools can be a vital aspect of the COVID-19 response, and some are already used by clinicians worldwide. A team of researchers led by Theodoros Zanos, PhD, an assistant professor at the Northwell Health’s Institute of Bioelectronic Medicine at Feinstein in New York City, wrote an article for the Springer Nature journal outlining the potential for critical care decision-making tools that include information …

AI is a ‘key ally in the fight’ against COVID-19, say Northwell researchers | Becker’s Hospital Review | 7/13/2020

Artificial intelligence and machine learning tools can be a vital aspect of the COVID-19 response, and some are already used by clinicians worldwide. A team of researchers led by Theodoros Zanos, PhD, an assistant professor at the Northwell Health’s Institute of Bioelectronic Medicine at Feinstein in New York City, wrote an article for the Springer Nature journal outlining the potential for critical care decision-making tools that include information …

Medical Center

Feinstein Institutes to Collect COVID-19 Patient Plasma, Research Antibodies Therapy | Business Wire | 4/10/2020

… who is being hospitalized with COVID-19 and being treated at North Shore University Hospital (NSUH) or Long Island Jewish Medical Center (LIJ), in hopes the infused antibodies will ward off infection. Additional Northwell Health … of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global …

BioSig Technologies Welcomes the Creation of New Bioelectronic Medicine Alliance | Globe Newswire | 11/18/2019

BioSig Supports the Alliance for Advancing Bioelectronic Medicine, Which Seeks to Bring Together Leading Experts to Advance Entire Field November 18, 2019 07:52 ET Source: BioSig Technologies, Inc. Westport, CT, BioSig Technologies, Inc. (NASDAQ: BSGM … Feinstein Institute, RAND Corporation, Battelle, Imperial College London, and Sheba Medical Center. “BioSig’s leadership and support have helped to connect bioelectronic medicine experts from diverse areas of the field, which has led to our forming …

North Shore University Hospital

Feinstein Institutes to Collect COVID-19 Patient Plasma, Research Antibodies Therapy | Business Wire | 4/10/2020

… yellow liquid. This plasma will be injected into someone who is being hospitalized with COVID-19 and being treated at North Shore University Hospital (NSUH) or Long Island Jewish Medical Center (LIJ), in hopes the … of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global …

Breast cancer patients benefit from new pain control regimen that shortens hospital stay after reconstruction | PR Newswire | 10/24/2017

… for their patients include Long Island Jewish Medical Center in New Hyde Park , Southside Hospital in Bay Shore , Huntington Hospital, North Shore University Hospital in Manhasset and Staten Island University Hospital. Dr. Smith, who presented … molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we empower imagination and pioneer discovery …

University Hospital

Feinstein Institutes to Collect COVID-19 Patient Plasma, Research Antibodies Therapy | Business Wire | 4/10/2020

… This plasma will be injected into someone who is being hospitalized with COVID-19 and being treated at North Shore University Hospital (NSUH) or Long Island Jewish Medical Center (LIJ), in hopes the infused antibodies … of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global …

Chief scientific officer and sepsis researcher recognized by Shock Society | PR Newswire | 7/23/2019

… a professor at the Feinstein Institutes, is the vice chairman for research in the department of surgery at North Shore University Hospital and Long Island Jewish Medical Center. He is also professor of surgery and … of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We’re making breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a …

Long Island Jewish Medical Center

Feinstein Institutes to Collect COVID-19 Patient Plasma, Research Antibodies Therapy | Business Wire | 4/10/2020

… injected into someone who is being hospitalized with COVID-19 and being treated at North Shore University Hospital (NSUH) or Long Island Jewish Medical Center (LIJ), in hopes the infused antibodies will ward off infection … of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global …

Chief scientific officer and sepsis researcher recognized by Shock Society | PR Newswire | 7/23/2019

… the Feinstein Institutes, is the vice chairman for research in the department of surgery at North Shore University Hospital and Long Island Jewish Medical Center. He is also professor of surgery and molecular medicine at … of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We’re making breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a …

North Hospital

Feinstein Institutes to Collect COVID-19 Patient Plasma, Research Antibodies Therapy | Business Wire | 4/10/2020

… New York State. Home to 50 research labs, 2,500 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has …

Chief scientific officer and sepsis researcher recognized by Shock Society | PR Newswire | 7/23/2019

… New York . Home to 50 research labs, 2,500 clinical research studies and 4,000 researchers and staff, the Feinstein Institutes is raising the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We’re making breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For …

Mayo Clinic

BioSig Technologies Partners Mayo Clinic to Treat Arrhythmia - December 2, 2019 - Zacks.com | 12/2/2019

… be integrated into the PURE EP. The company also plans to utilize the licensed intellectual properties and products developed by Mayo Clinic over the past few years, through the FDA approval. These will, then, be … and support in the launch of the Alliance for Advancing Bioelectronic Medicine (AABM), an independent network of professionals united to support bioelectronic medicine in November 2019. In September, BioSig entered into a new licensing agreement …

BioSig Technologies Partners Mayo Clinic to Treat Arrhythmia | Zacks | 12/2/2019

BioSig Technologies Partners Mayo Clinic to Treat Arrhythmia Zacks Equity Research Zacks Equity Research Zacks Equity Research Cancel BioSig Technologies, Inc. ( BSGM - Free Report ) has announced that the company and its majority-owned subsidiary have … and support in the launch of the Alliance for Advancing Bioelectronic Medicine (AABM), an independent network of professionals united to support bioelectronic medicine in November 2019.In September, BioSig entered into a new licensing agreement …

Greenville Memorial Hospital

BioSig Technologies Partners Mayo Clinic to Treat Arrhythmia - December 2, 2019 - Zacks.com | 12/2/2019

Bioelectronic Medicine (AABM), an independent network of professionals united to support bioelectronic medicine in November 2019. In September, BioSig entered into a new licensing agreement with Mayo Clinic to develop a new product pipeline to support some of the more advanced features of PURE EP. BioSig had conducted patient cases using PURE EP System at Greenville Memorial Hospital — part of Prisma Health System — in April. Further, in February, BioSig had …

BioSig Technologies Partners Mayo Clinic to Treat Arrhythmia | Zacks | 12/2/2019

Bioelectronic Medicine (AABM), an independent network of professionals united to support bioelectronic medicine in November 2019.In September, BioSig entered into a new licensing agreement with Mayo Clinic to develop a new product pipeline to support some of the more advanced features of PURE EP.BioSig had conducted patient cases using PURE EP System at Greenville Memorial Hospital — part of Prisma Health System — in April. Further, in February, BioSig had successfully …

Massachusetts General Hospital

Bioelectronic Medicine Startup Cala Health Nabs $50M for Wearable Neuromodulation Therapies | HIT Consultant | 5/23/2019

Bioelectronic Medicine Startup Cala Health Nabs $50M for Wearable Neuromodulation Therapies //hitconsultant.net/2019/05/22/bioelectronic-medicine-startup-cala-health-funding/. Captcha Submit Cala Health, Inc., a San Francisco, CA-based bioelectronic medicine company developing wearable therapies … and ongoing collaboration with Partners Healthcare Innovation and its affiliate, Massachusetts General Hospital,” said Kate Rosenbluth, Ph.D., Founder and CEO, Cala Health …

Bioelectronic medicine — for back pain, brain cancer, and more — may be the fastest-growing alternative to drugs - The Boston Globe | 12/6/2017

… CLINICAL TRIAL came to the attention of Dr. Andrew Cole, a neurologist and the director of the Epilepsy Service at Massachusetts General Hospital. The trial was to establish the effectiveness of a new device for … made by Silicon Valley-based NeuroPace, is an example of bioelectronic medicine, which uses electricity to treat disease. Previous epilepsy neurostimulators worked like an alarm clock, stimulating the brain on a set schedule. The NeuroPace …

University Medical Center

Psychiatry’s Brave New World–FDA Approves Digital Sensor in Antipsychotic Drug to Enforce Prescription Compliance | PR Newswire | 1/11/2018

… breaches of medical data or unauthorized use as a surveillance tool, said James Giordano , a professor of neurology at Georgetown University Medical Center. “Could this type of device be used for real-time surveillance? The … or alter signals in the nerve.[14] It is called bioelectronic medicines or as GlaxoSmithKline coined, “electroceuticals.”[15] In March 2016 , The Wall Street Daily reported, “A number of pharmaceutical companies will eventually transform into …

Psychiatry’s Brave New World–FDA Approves Digital Sensor in Antipsychotic Drug to Enforce | PR Newswire | 1/11/2018

… breaches of medical data or unauthorized use as a surveillance tool, said James Giordano , a professor of neurology at Georgetown University Medical Center. “Could this type of device be used for real-time surveillance? The … or alter signals in the nerve.[14] It is called bioelectronic medicines or as GlaxoSmithKline coined, “electroceuticals.”[15] In March 2016 , The Wall Street Daily reported, “A number of pharmaceutical companies will eventually transform into …

Kevin J. Tracey

Long-Sought Breakthrough in Sepsis Research Offers New Treatments to Prevent Death | Business Wire | 4/15/2020

… of death in hospitals and Dr. Wang’s research is a huge step in stopping this escalating and urgent crisis,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes. “His work is a … of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global …

Haichao Wang

Long-Sought Breakthrough in Sepsis Research Offers New Treatments to Prevent Death | Business Wire | 4/15/2020

… the association between a harmless protein and a disease mediator that could lead to sepsis death. The research, led by Haichao Wang, PhD, professor in the Institute of Molecular Medicine at Feinstein, published today in … of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global …

Kevin Tracey

Long-Sought Breakthrough in Sepsis Research Offers New Treatments to Prevent Death | Business Wire | 4/15/2020

… New York State. Home to 50 research labs, 2,500 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has …

Dan Goldberg

electroCore Announces Fourth Quarter and Full Year 2019 Financial Results | Globe Newswire | 3/23/2020

… today, March 23, 2020 at 4:45 pm ET BASKING RIDGE, N.J., March 23, electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced fourth quarter 2019 financial results and provided an operational update … demonstrating that our sharpened commercial growth strategy is working,” stated Dan Goldberger, Chief Executive Officer of electroCore. “We are pursuing these opportunities, mindful that we need to do so as efficiently as possible. In support …

Michael Dowling

Feinstein Institutes begins enrolling patients in multiple COVID-19 clinical trials | Business Wire | 3/20/2020

… suffering from COVID-19 and are determined to do all we can to stop the virus in its tracks,” said Michael Dowling, president and CEO of Northwell Health. While there is a nationwide push for … of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global …

Raj Narayan

Feinstein Institutes CEO to Present Elsberg Lecture About Bioelectronic Medicine | Business Wire | 1/28/2020

MANHASSET, N.Y.- The Feinstein Institutes for Medical Research President and CEO Kevin J. Tracey, MD , will present the New York Society for Neurosurgery (NYSN) 2020 Elsberg Lecture about the emerging field of bioelectronic medicine . Dr. Tracey’s lecture will be delivered January 29 at 6:30 pm at The University Club of New York. To register for the event, click here . The Elsberg Lecture is named for Charles. A. Elsberg, one of …

Jennifer Ernst

Tivic Health’s ClearUP Sinus Pain Relief Named To TIME’S List Of The 100 Best Inventions Of 2019 | PR Newswire | 11/22/2019

… million Americans suffering from allergic rhinitis. Available now over the counter and without a prescription. ClearUP is an example of bioelectronic medicine, an emerging form of drug free, non-invasive medicine that uses low-level … healthcare and be among such distinguished and accomplished innovators,” said Jennifer Ernst , CEO of Tivic Health. “The bioelectronics industry is generating new non-drug therapies and this new class of devices represents an emerging vertical …

Peter Davies

Oligomerix and Feinstein Institutes Publish In Vivo Alzheimer’s Disease Treatment Data | Business Wire | 11/19/2019

… for new approaches to the treatment of Alzheimer’s disease, and this study describes promising results with a novel compound,” said Peter Davies, Ph.D ., director of the Litwin-Zucker Center for Alzheimer’s Disease & Memory Disorders at … of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We’re making breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a …

Ping Wang

Sepsis discovery could lead to new inflammation treatment | PR Newswire | 11/14/2019

MANHASSET, N.Y. , Nov. 14, The Feinstein Institutes for Medical Research Professor Ping Wang , MD , and colleagues have discovered a new way to reduce sepsis inflammation, according to a paper published in the latest EMBO Reports … of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We’re making breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a …

Barbara Zucker

Northwell Health announces endowment program as part of billion-dollar campaign | PR Newswire | 10/31/2019

… said Lawrence Smith , MD, executive vice president and physician-in-chief for Northwell Health and dean of the Donald and Barbara Zucker School of Medicine at Hofstra /Northwell. “We are grateful to our generous donors … the molecular mechanism for the inflammatory reflex and creator of bioelectronic medicine, has been appointed to this post. Additionally, the Karches Family Foundation funded the Kanti R. Rai, MD Professor in Cancer Research in honor …

Kate Rosenbluth

Cala Health Announces Positive Topline Data from Landmark PROSPECT Study for Essential Tremor (ET) | Business Wire | 9/23/2019

BURLINGAME, Calif.–(BUSINESS WIRE)–Sep 23, 2019– Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, will present positive topline data from the landmark PRO spective study for S ym P … brings to patients with ET, without surgery or drugs,” said Kate Rosenbluth, Founder and Chief Scientific Officer at Cala Health. “We are deeply grateful to the patients and investigators who participated in this study.” Cala …

Francis Amato

electroCore Selected for Innovation and Technology Payment Program Through NHS England | Globe Newswire | 5/6/2019

… electroCore, Inc. LONDON and BASKING RIDGE, N.J., May 06, 2019 (GLOBE NEWSWIRE) – electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that gammaCore, the company’s non-invasive vagus nerve stimulator (nVNS … patients who might benefit from the use of gammaCore,” said Francis Amato, chief executive officer of electroCore. “We look forward to working with NHS England to provide significant cost savings and improve patient care while …